Dear Colleaques,
The Immunization for Resilience newsletter is delighted to announce our first commentary in the peer-reviewed journal, Human Vaccines & Immunotherapeutics, Taylor & Francis Group.
“Closing the Hepatitis B Birth-Dose Gap in Cameroon: Global Evidence and Policy Imperatives,” outlines an evidence-based strategy to close the birth-dose gap in Cameroon and offers insights for other high-burden settings. This publication comes at a crucial time amid renewed discussion of the hepatitis B birth-dose in the United States.
Sincere thanks to readers of the Immunization for Resilience newsletter for your continued engagement—and to those who provided invaluable feedback on the Cameroon hepatitis B vaccination post.
Read the full article at https://lnkd.in/egd-VSmm
I will be happy to receive feedback.
📬 Subscribe to my weekly updates on global health challenges, humanitarian crises, and evidence-based strategies for creating lasting public-health impact at https://www.linkedin.com/pulse/closing-hepatitis-b-birth-dose-gap-cameroon-global-tambe-qwcde
Tambe Elvis Akem – Medical Field Epidemiologist | Health & Immunization Specialist | Advocate for Equity in Health
@ImmunizationForResilienceNewsletter